Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma
Status:
Not yet recruiting
Trial end date:
2024-07-31
Target enrollment:
Participant gender:
Summary
This study is a card Rayleigh bead single combined cisplatin treatment of advanced squamous
cell carcinoma of the skin resistance of single arm phase II study, open, single center, plan
in two years into the group of 20 cases with histologic diagnosis of lymph node metastasis or
distant metastasis CSCC of (1) or surgery can't/couldn't thorough radiotherapy, CSCC of
locally advanced (class 2), To evaluate the efficacy of camrelizumab (PD-1 mab) combined with
cisplatin in the treatment of advanced CSCC.